Functional electrical stimulation-assisted cycle ergometry-based progressive mobility programme for mechanically ventilated patients: randomised controlled trial with 6 months follow-up.
Critical Illness
/ rehabilitation
Electric Stimulation
Ergometry
/ methods
Exercise Therapy
/ methods
Female
Follow-Up Studies
Humans
Intensive Care Units
Male
Middle Aged
Muscle Strength
/ physiology
Muscle Weakness
/ physiopathology
Prospective Studies
Quality of Life
Respiration, Artificial
/ methods
Time Factors
complementary medicine
critical care
Journal
Thorax
ISSN: 1468-3296
Titre abrégé: Thorax
Pays: England
ID NLM: 0417353
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
07
07
2020
revised:
15
03
2021
accepted:
06
04
2021
pubmed:
2
5
2021
medline:
14
7
2021
entrez:
1
5
2021
Statut:
ppublish
Résumé
Functional electrical stimulation-assisted cycle ergometry (FESCE) enables in-bed leg exercise independently of patients' volition. We hypothesised that early use of FESCE-based progressive mobility programme improves physical function in survivors of critical care after 6 months. We enrolled mechanically ventilated adults estimated to need >7 days of intensive care unit (ICU) stay into an assessor-blinded single centre randomised controlled trial to receive either FESCE-based protocolised or standard rehabilitation that continued up to day 28 or ICU discharge. We randomised in 1:1 ratio 150 patients (age 61±15 years, Acute Physiology and Chronic Health Evaluation II 21±7) at a median of 21 (IQR 19-43) hours after admission to ICU. Mean rehabilitation duration of rehabilitation delivered to intervention versus control group was 82 (IQR 66-97) versus 53 (IQR 50-57) min per treatment day, p<0.001. At 6 months 42 (56%) and 46 (61%) patients in interventional and control groups, respectively, were alive and available to follow-up (81.5% of prespecified sample size). Their Physical Component Summary of SF-36 (primary outcome) was not different at 6 months (50 (IQR 21-69) vs 49 (IQR 26-77); p=0.26). At ICU discharge, there were no differences in the ICU length of stay, functional performance, rectus femoris cross-sectional diameter or muscle power despite the daily nitrogen balance was being 0.6 (95% CI 0.2 to 1.0; p=0.004) gN/m Early delivery of FESCE-based protocolised rehabilitation to ICU patients does not improve physical functioning at 6 months in survivors. NCT02864745.
Identifiants
pubmed: 33931570
pii: thoraxjnl-2020-215755
doi: 10.1136/thoraxjnl-2020-215755
pmc: PMC8223653
doi:
Banques de données
ClinicalTrials.gov
['NCT02864745']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
664-671Commentaires et corrections
Type : CommentIn
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
JAMA. 2008 Oct 8;300(14):1685-90
pubmed: 18840842
Intensive Care Med. 2016 May;42(5):725-738
pubmed: 27025938
N Engl J Med. 2011 Apr 7;364(14):1293-304
pubmed: 21470008
Crit Care Med. 2020 Jul;48(7):1055-1065
pubmed: 32345834
J Crit Care. 2014 Aug;29(4):695.e1-7
pubmed: 24768534
J Spinal Cord Med. 2015 Jan;38(1):23-37
pubmed: 25001669
Crit Care. 2010;14(2):R74
pubmed: 20426834
Chest. 2003 Jul;124(1):292-6
pubmed: 12853536
N Engl J Med. 2008 Mar 27;358(13):1327-35
pubmed: 18367735
N Engl J Med. 2014 Apr 24;370(17):1626-35
pubmed: 24758618
Am J Physiol. 1996 Jul;271(1 Pt 2):R191-9
pubmed: 8760220
JAMA. 2018 Jul 24;320(4):368-378
pubmed: 30043066
Lancet. 2009 May 30;373(9678):1874-82
pubmed: 19446324
Crit Care. 2015 Mar 29;19:127
pubmed: 25888469
AACN Clin Issues. 2002 May;13(2):263-76
pubmed: 12011598
Health Serv Res. 2005 Apr;40(2):577-91
pubmed: 15762908
Crit Care Med. 2016 Jun;44(6):1145-52
pubmed: 26968024
Am J Respir Crit Care Med. 2016 May 15;193(10):1101-10
pubmed: 26651376
Crit Care Med. 2007 Jan;35(1):139-45
pubmed: 17133183
Clin Rehabil. 2015 Nov;29(11):1051-63
pubmed: 25681407
J Crit Care. 2015 Feb;30(1):32-9
pubmed: 25307979
Trials. 2019 Dec 16;20(1):724
pubmed: 31842936
Intensive Care Med. 2015 May;41(5):865-74
pubmed: 25851383
JAMA. 2016 Jun 28;315(24):2694-702
pubmed: 27367766
Medicine (Baltimore). 2018 Nov;97(46):e13012
pubmed: 30431575
Crit Care. 2013 Jul 24;17(4):R156
pubmed: 23883525
Thorax. 2018 Mar;73(3):213-221
pubmed: 28780504
CMAJ. 2008 Mar 11;178(6):725-6
pubmed: 18332388
Crit Care. 2008;12(6):238
pubmed: 19040777
Thorax. 2021 Jul;76(7):656-663
pubmed: 33323480
Intensive Care Med. 2014 Apr;40(4):548-55
pubmed: 24477456
J Rehabil Med. 2017 Jan 19;49(1):40-48
pubmed: 28101565
Mitochondrion. 2015 Mar;21:106-12
pubmed: 25701243
Phys Ther. 2013 Dec;93(12):1636-45
pubmed: 23886842
JAMA. 2013 Oct 16;310(15):1591-600
pubmed: 24108501
Yale J Biol Med. 2012 Jun;85(2):201-15
pubmed: 22737049
Assist Technol. 1999;11(2):88-96
pubmed: 11010069
Arch Phys Med Rehabil. 2018 Jun;99(6):1220-1225
pubmed: 29580936
Crit Care. 2016 Jan 29;20:30
pubmed: 26825278
Phys Ther. 2014 Oct;94(10):1499-507
pubmed: 24810863
Crit Care. 2009;13(5):R161
pubmed: 19814793
PLoS One. 2019 Mar 1;14(3):e0200228
pubmed: 30822305